No trading action warranted. Monitor for future pipeline catalysts or clinical data readouts, which are the primary value drivers for this pre-revenue biotech.
Price Chart
Executive Summary
IDEAYA Biosciences filed an 8-K reporting results from its 2026 Annual Meeting of Stockholders, where all three proposals passed: election of three Class I directors, ratification of PricewaterhouseCoopers as auditor, and advisory approval of executive compensation. Separately, the Board elected CEO Yujiro S. Hata as Chairman and Terry Rosen as Lead Independent Director. This is a routine governance filing with no material financial or operational impact.
Key Facts
- Annual Meeting held June 16, 2026; all three proposals passed.
- Directors elected: Yujiro S. Hata (70.5M for), M. Garret Hampton (56.7M for), Catherine J. Mackey (70.3M for).
- Ratification of PwC as auditor: 82.6M for, 141K against.
- Advisory vote on executive compensation: 64.3M for, 8.3M against.
- Board elected Yujiro S. Hata as Chairman and Terry Rosen as Lead Independent Director, effective June 16, 2026.
- 87,860,920 shares outstanding and entitled to vote as of record date April 20, 2026.
Financial Impact
No financial impact; routine governance and board leadership changes.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-279427 |
| Document: 0001193125-26-279427-index-headers.html | 0001193125-26-279427 |
| Document: 0001193125-26-279427-index.html | 0001193125-26-279427 |
| Document: 0001193125-26-279427.txt | 0001193125-26-279427 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 8w ago | 8-K | $36.11 $39.95 | ▲ +10.63% | ▲ +11.87% | $37.34 (+3.41%) |
Jun 23, 2026 14w ago | 8-K | $36.28 $35.00 | ▼ −3.53% | ▼ −5.46% | $37.34 (+2.92%) |
Jun 10, 2026 16w ago | 8-K | $28.84 $37.28 | ▼ −29.26% | ▼ −27.37% | $37.34 (−29.47%) |
Jun 9, 2026 16w ago | 424B5 | $27.60 $37.28 | ▼ −35.07% | ▼ −31.45% | $37.34 (−35.29%) |
Jun 8, 2026 16w ago | 424B5 | $28.07 $40.51 | ▼ −44.32% | ▼ −42.87% | $37.34 (−33.02%) |
Jun 3, 2026 17w ago | 8-K | $28.40 $37.65 | ▲ +32.57% | ▲ +33.57% | $37.34 (+31.48%) |
May 5, 2026 21w ago | 8-K | $28.74 $28.40 | ▼ −1.18% | ▼ −3.96% | $37.34 (+29.92%) |
May 5, 2026 21w ago | 424B5 | $28.74 $28.40 | ▼ −1.18% | ▼ −3.96% | $37.34 (+29.92%) |
Apr 13, 2026 24w ago | 8-K | $32.82 $28.13 | ▼ −14.29% | ▼ −22.02% | $37.34 (+13.77%) |
Apr 9, 2026 25w ago | 8-K | $31.00 $28.74 | ▼ −7.29% | ▼ −14.86% | $37.34 (+20.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access